ClinicalTrials.Veeva

Menu

An Online Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young Adults

University of Southern California logo

University of Southern California

Status

Enrolling

Conditions

E-cigarette Use

Treatments

Behavioral: Live Free From E-cigarettes

Study type

Interventional

Funder types

Other

Identifiers

NCT06129123
UP-23-00005-AM001

Details and patient eligibility

About

The goal of this intervention development and pilot clinical trial is to determine whether receiving the brief online intervention results in greater reductions in past 7-day e-cigarette use frequency and smoking susceptibility over an 8-week period compared to receiving the control condition in young adults who currently use e-cigarettes. Participants in the experimental condition will be asked to complete the 30-minute mobile-based program. Participants in the assessment-only control will be given the option to access the intervention after they complete their final survey at 8 weeks. All participants will complete our online surveys at baseline as well as 2-weeks, 4-weeks, and 8-weeks post-randomization. Researchers will compare outcomes among the intervention and control groups to determine the efficacy of the intervention.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 24 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • be between the ages of 18 to 24
  • be able to read English
  • report vaping at least one day per week in the past month
  • report no history of cigarette use at screening and baseline.

Exclusion criteria

  • reporting severe mental health, illicit drug use, or alcohol use disorder
  • currently receiving nicotine cessation services

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Intervention
Experimental group
Description:
Participants will be asked to complete a 30-minute intervention that is accessible on a mobile device, delivered via a webpage, and personalized to their individual vaping behavior and beliefs (based on the baseline surveys). The intervention will contain personalized normative feedback (PNF), Motivational Enhancement (ME), and education. Participants will complete assessments at baseline as well as 2-weeks, 4-weeks, and 8-weeks post randomization.
Treatment:
Behavioral: Live Free From E-cigarettes
Waitlist Control
No Intervention group
Description:
Participants will complete assessments at baseline as well as 2-weeks, 4-weeks, and 8-weeks post randomization. They will not receive the intervention during the active study phase, lasting 8 weeks. Participants will have the option to access the intervention once this active study phase is over.

Trial contacts and locations

1

Loading...

Central trial contact

I-Wen Contracts and Grants Coordinator

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems